Showing results (221-230 of 761) with videos related to
Sort By:
Pageof 77
Nature Reviews. Nephrology|July 1, 2018
The role of B7-1 in proteinuria of glomerular originRubina Novelli, Ariela Benigni, Giuseppe RemuzziCurrent Opinion in Pharmacology|April 30, 2017
New biologics in the treatment of rare glomerular diseases of childhoodPaolo Cravedi, Andrea Angeletti, Giuseppe RemuzziThe New England Journal of Medicine|July 24, 2009
Thrombomodulin mutations in atypical hemolytic-uremic syndromeMieke Delvaeye, Marina Noris, Astrid De Vriese, et al.Blood Purification|March 27, 2004
Nitric oxide synthetic capacity in relation to dialysate temperatureCharles H Beerenhout, Marina Noris, Jeroen P Kooman, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 9, 2010
Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibilityNorberto Perico, Federica Casiraghi, Martino Introna, et al.Frontiers in Immunology|June 26, 2024
Proof of concept of a new plasma complement Factor H from waste plasma fractionFilippo Mori, Giancarlo Pascali, Silvia Berra, et al.Scientific Reports|September 16, 2017
Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survivalSistiana Aiello, Federica Rocchetta, Lorena Longaretti, et al.Journal of the American Society of Nephrology : JASN|February 23, 2013
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotypeElena Bresin, Erica Rurali, Jessica Caprioli, et al.Proceedings of the National Academy of Sciences of the United States of America|February 13, 2008
Mutations in FN1 cause glomerulopathy with fibronectin depositsFederica Castelletti, Roberta Donadelli, Federica Banterla, et al.Blood|July 20, 2014
Dynamics of complement activation in aHUS and how to monitor eculizumab therapyMarina Noris, Miriam Galbusera, Sara Gastoldi, et al.Pageof 77